What Campral is
Campral is a medicine containing acamprosate calcium, a substance used as part of treatment for alcohol dependence. It is intended to support continued abstinence after alcohol withdrawal has been completed. Campral works best alongside counselling, psychosocial support, and a personalised recovery plan.
Acamprosate was developed after research into the chemical changes that can persist in the brain following long-term alcohol exposure. Its clinical use became established as evidence showed that it could help some abstinent adults maintain alcohol-free recovery. It is not a medicine that causes intoxication or substitutes for alcohol.
In Norway, treatment for alcohol dependence should be approached with support from qualified healthcare professionals. A prescriber can assess whether acamprosate fits the person’s health status, current medicines, and treatment goals. This assessment is especially important after detoxification or if alcohol use has recently stopped.
How acamprosate works
Alcohol can disrupt the balance between excitatory and inhibitory signalling systems in the brain. Acamprosate is thought to help stabilise this imbalance during abstinence, particularly through effects on glutamate-related signalling. Its exact clinical mechanism is not fully defined.
The medicine is not designed to treat acute alcohol withdrawal symptoms, alcohol intoxication, or an alcohol-related emergency. It does not remove the need for medically supervised withdrawal where this is indicated. People at risk of severe withdrawal should seek urgent medical assessment rather than rely on Campral.
Campral may reduce the distressing drive to return to drinking for some people who have already stopped alcohol use. Response differs between individuals and may take time to evaluate. Continued counselling and practical relapse-prevention measures remain central to treatment.
Uses and expected treatment role
Campral is principally used to help maintain abstinence in adults with alcohol dependence. It is generally started after alcohol detoxification, when the patient is no longer drinking. Starting or continuing treatment while drinking should be discussed with the prescriber.
The medicine is usually one element of a broader programme that may include psychological therapy, peer support, family involvement, and management of mental health conditions. No tablet can address every social, medical, or behavioural factor involved in alcohol dependence. Regular follow-up gives an opportunity to review progress and barriers to recovery.
Campral is not normally used as a treatment for anxiety, insomnia, depression, or pain, even though these conditions may occur during recovery. Symptoms such as persistent low mood, suicidal thoughts, confusion, or hallucinations require prompt professional attention. Alcohol dependence can involve serious physical and mental health risks that need comprehensive care.
Forms, strengths, and administration
Campral is commonly supplied as gastro-resistant tablets containing 333 mg of acamprosate calcium. The coating is designed to protect the tablet until it reaches the intestine. Tablets should generally be swallowed whole with water rather than crushed or chewed.
The prescribed dose depends on the product information, body weight, kidney function, and clinical judgement. A commonly used adult regimen consists of doses taken three times a day, but patients should follow the directions on their own dispensing label. Do not change the dose or stop treatment solely because cravings improve or side effects occur.
Taking doses at consistent times can help make treatment easier to remember. If a dose is missed, the patient should follow the advice provided by their pharmacist or prescriber rather than doubling the next dose. A medicine reminder or dosing diary may be helpful where appropriate.
Duration of effect and clearance from the body
Acamprosate is taken regularly because its treatment effect depends on maintaining consistent exposure over time. It is not expected to provide an immediate, noticeable effect after a single tablet. The benefit is assessed across ongoing abstinence and supportive treatment rather than hour by hour.
The body eliminates acamprosate mainly through the kidneys, with little evidence of significant metabolism by the liver. Its elimination half-life is commonly described as being in the range of several hours, although this can vary between individuals. Reduced kidney function can increase exposure and may make treatment unsuitable or require a different approach.
After treatment is stopped, acamprosate is generally cleared over the following days, but the exact timeframe depends on kidney function and other individual factors. The absence of the medicine does not mean recovery support should end. Patients should discuss any planned discontinuation with their treating clinician.
Scientific evidence and treatment expectations
Clinical research has evaluated acamprosate as a relapse-prevention medicine for alcohol dependence in people who have achieved abstinence. Across studies, results support a benefit for some patients in maintaining alcohol-free periods when the medicine is combined with psychosocial care. Individual outcomes vary, and it is not effective for every person.
Research findings should be interpreted in the context of the participant population, treatment setting, adherence, and accompanying therapy. A prescriber may consider previous treatment attempts, medical history, and patient preference when deciding whether Campral is appropriate. Follow-up allows the treatment plan to be adapted if it is not helping.
Campral is not regarded as addictive, and it does not usually produce a rewarding or sedating effect. It is not known to cause dependence in the way alcohol, opioids, or certain sedative medicines can. Nonetheless, it should be taken only as directed and kept out of reach of others.
Side effects and allergic reactions
The most frequently reported adverse effect with acamprosate is diarrhoea. Other possible effects include abdominal discomfort, nausea, itching, rash, headache, dizziness, sleep disturbance, or changes in sexual function. Many effects are mild, but persistent or troublesome symptoms should be discussed with a healthcare professional.
A serious allergic reaction is uncommon but requires urgent care. Warning signs can include swelling of the face, lips, tongue, or throat; breathing difficulty; widespread hives; or a severe blistering rash. Anyone with these symptoms should stop taking the medicine and seek emergency medical help.
Mood changes deserve particular attention during treatment for alcohol dependence. People with depression, worsening anxiety, self-harm thoughts, or suicidal thoughts should contact a clinician urgently or use emergency services when immediate danger is present. Family members and carers may also help by watching for significant behavioural changes.
Who should not take Campral
Campral should not be used by anyone with a known allergy to acamprosate or any ingredient in the particular product. It is also generally unsuitable for people with severe kidney impairment because the medicine is cleared through the kidneys. The prescriber may need recent kidney-function information before treatment begins.
Pregnancy and breastfeeding require an individual discussion with a clinician, as the potential benefits and uncertainties need careful consideration. People with significant liver disease, mental health conditions, or multiple medicines should also receive tailored advice. Alcohol dependence itself can affect nutrition, mood, sleep, and organ health, making a full assessment valuable.
Campral is intended for adults and is not routinely established for use in children or adolescents. Older adults may require particular attention to kidney function and other health conditions. Age alone does not determine suitability, but it can influence monitoring and medicine selection.
Alcohol, interactions, and other precautions
Campral does not create the same alcohol reaction associated with disulfiram, but alcohol use can undermine the purpose of treatment. Drinking while taking it should be discussed honestly with the care team rather than treated as a reason to abandon support. A lapse can be clinically important, yet it can also be an opportunity to adjust relapse-prevention care.
Acamprosate has relatively limited interaction potential because it is not extensively processed by liver enzyme systems. Even so, patients should provide a complete list of prescription medicines, non-prescription products, supplements, and recreational substances. This enables clinicians to identify risks related to the overall treatment plan rather than Campral alone.
Alcohol withdrawal can be dangerous, particularly for people with a history of seizures, delirium, severe withdrawal, or substantial daily alcohol consumption. Emergency symptoms include seizures, confusion, severe agitation, fever, or hallucinations. Such symptoms require urgent medical care and should not be managed through self-treatment.
Overdose and urgent action
Taking more Campral than prescribed may increase the likelihood of gastrointestinal symptoms, including severe diarrhoea. The clinical effects of overdose can vary, especially when alcohol or other medicines have also been taken. Do not wait for symptoms to become severe before seeking advice.
In Norway, contact the Norwegian Poison Information Centre, a doctor, or emergency services for suspected overdose, depending on the circumstances and severity. If there is collapse, breathing difficulty, a seizure, marked confusion, or reduced consciousness, call emergency services immediately. Keep the medicine package available so professionals can identify the product and strength.
Do not induce vomiting unless specifically instructed by a poison specialist or clinician. Avoid taking additional medicines to counteract symptoms without professional advice. Safe storage and clear labelling reduce the risk of accidental ingestion by children or other household members.
Storage and responsible handling
Store Campral in its original package, protected from unnecessary moisture and kept according to the product leaflet. Normal room-temperature storage is usually appropriate unless the dispensing label gives different instructions. Keep the package out of sight and reach of children.
Do not use tablets after the expiry date or if the packaging is damaged and the product’s integrity is uncertain. Unused or expired medicines should be returned to a pharmacy for safe disposal. They should not be shared with another person, even where symptoms appear similar.
Keeping an updated medicines list can improve safety during appointments, hospital visits, or travel. Patients should carry sufficient medication only when it has been appropriately supplied and labelled. Travel across borders may involve documentation requirements, so travellers should check relevant rules in advance.
Prescription status and pharmacy supply in Norway
Campral is a prescription medicine, so a legitimate pharmacy supply requires a valid prescription and appropriate professional review. It should not be obtained without prescription, because kidney status, treatment timing, and alcohol-dependence care need individual assessment. Any website suggesting unrestricted supply should be treated cautiously.
A regulated web pharmacy can process a prescription in accordance with Norwegian requirements and its professional procedures. The pharmacy should clearly identify itself, provide contact details, protect personal data, and offer access to pharmacist support. Patients should avoid sellers that conceal their location or offer medicines with no meaningful health screening.
Before dispensing, the pharmacy may need to confirm prescription details, patient identity, delivery eligibility, and any questions raised during pharmaceutical review. These steps are safeguards, not unnecessary obstacles. They help ensure that the supplied medicine and instructions match the prescriber’s plan.
Campral price and value considerations
Campral price can vary between pharmacies, pack sizes, reimbursement circumstances, dispensing fees, and current commercial arrangements. It is sensible to view any displayed amount as indicative until the prescription, available pack, and delivery method have been confirmed. A pharmacy can explain the final cost before payment is completed.
Cost should not be the only criterion when selecting a pharmacy. Verified supply chains, pharmacist access, secure payment handling, and transparent delivery terms are important for prescription medicines. Extremely low offers from unverified sellers may indicate counterfeit, unsuitable, or unlawfully supplied products.
Patients who may qualify for reimbursement or support should ask their prescriber or pharmacy about the applicable Norwegian arrangements. Reimbursement rules can depend on diagnosis, documentation, and current policy. The pharmacy should not promise coverage before the relevant eligibility information has been checked.
Alternative approaches to alcohol-dependence treatment
Alternatives to Campral may include other medicines used in alcohol-dependence treatment, such as naltrexone, disulfiram, or medicines used in selected clinical circumstances. Each has different benefits, contraindications, interaction considerations, and treatment goals. A clinician should determine whether any alternative is suitable.
Psychological and social interventions are essential alternatives as well as complements to medicine. Structured counselling, cognitive behavioural approaches, mutual-help programmes, family support, and specialist addiction services can each have a role. The best combination depends on the individual’s circumstances and preferences.
Changing medication should not be done abruptly without discussing it with the prescriber. Previous treatment response, current alcohol use, liver and kidney health, and co-occurring conditions all influence the choice. A non-judgemental discussion of setbacks can help create a safer and more realistic plan.
Benefits of using a regulated web pharmacy
A regulated digital pharmacy can make repeat prescription handling more convenient for people who prefer to manage requests from home. It may offer clear medicine information, secure communication, and delivery options suited to the patient’s location. Convenience should always be balanced with the need for clinical follow-up.
Reliable services provide transparent information about prescription verification, product availability, delivery charges, and expected dispatch. They should also make it straightforward to contact a pharmacist with medicine-related questions. Personal health information should be handled through secure systems.
For a medicine such as Campral, a responsible pharmacy service supports rather than replaces the patient’s treating team. The patient should continue attending planned appointments and report side effects, alcohol use, or changes in mental health. Pharmacy access is most useful when it is integrated with ongoing recovery care.
Requesting supply and tracking delivery
To request Campral through our pharmacy service, submit the required prescription details through the secure process and select an eligible delivery option. The pharmacy team reviews the request before supply and may contact the patient if clarification is needed. Processing times can vary with prescription verification and stock availability.
Once a shipment has been accepted for dispatch, package tracking information is normally provided through the delivery service where available. Tracking helps the recipient monitor progress and plan for receipt of a medicine parcel. Delivery updates do not replace contacting the pharmacy if the package is delayed, damaged, or missing.
Check the package and product name when it arrives, and read the supplied leaflet before taking the first dose. Contact the pharmacy promptly if the medicine, strength, quantity, or instructions do not match what was expected. For urgent symptoms, suspected overdose, or serious allergic reactions, seek medical help rather than waiting for a delivery or customer-service response.
Frequently asked questions about Campral
Is Campral the same medicine as acamprosate calcium?
Campral is a brand name for acamprosate calcium. The active ingredient may also be supplied under another brand or as a generic medicine; the pharmacy label and patient leaflet should identify the strength and ingredients.
Is Campral habit-forming?
Campral is not considered an addictive or controlled medicine and does not produce an intoxicating effect. It is used as part of a broader alcohol-dependence treatment plan, rather than as a replacement for alcohol or sedative medicines.
Can Campral cause a positive result on a workplace drug test?
Routine workplace drug panels are generally not designed to test for acamprosate. However, testing methods differ, so it is sensible to disclose prescribed medicines to the testing provider in line with their process.
Do people usually need regular blood tests while taking Campral?
Testing needs are individual and are decided by the prescriber. A clinician may review overall health and kidney function when clinically appropriate, particularly if there are existing health conditions or changes in wellbeing.
What should be discussed at a Campral follow-up appointment?
A follow-up can cover progress towards alcohol-free goals, adherence, unwanted effects, mental wellbeing, and any changes to other medicines or health conditions. It is also an opportunity to discuss practical support such as counselling or recovery services.
Can Campral affect fertility, pregnancy, or breastfeeding?
If you are trying to conceive, are pregnant, or are breastfeeding, discuss Campral with a qualified healthcare professional before using it. The decision requires an individual assessment of potential benefits, uncertainties, and the importance of treating alcohol dependence safely.
Why can the Campral packaging or tablet appearance differ from a previous supply?
Packaging, leaflet design, and tablet markings can vary between manufacturers, batches, and approved supplies. Check the pharmacy label, active ingredient, strength, expiry date, and patient leaflet, and ask a pharmacist if anything appears unexpected.
Which non-active ingredients should I check before using Campral?
Check the patient leaflet for excipients if you have known allergies, intolerances, dietary restrictions, or sensitivity to specific ingredients. A pharmacist can help interpret the ingredient list for the exact pack supplied.
Is it appropriate to share Campral with another person who wants to stop drinking?
No. Campral should only be used by the person for whom it was supplied, following an individual clinical assessment. Another person may have different medical needs, kidney function, medicines, or safety considerations.
What information on the pack helps identify a legitimate Campral supply in Norway?
A legitimate supply should have intact packaging, a clear medicine label, batch details, an expiry date, and the required product information. In Norway, use a pharmacy that provides identifiable contact details and access to a pharmacist or other qualified professional for medicine queries.
What should I do if the supplied Campral does not match the description on my label?
Do not rely on appearance alone or take extra tablets to compensate. Contact the dispensing pharmacy promptly with the pack and label available so it can confirm the product, strength, and appropriate next step.
Pharmacist Review
This Campral product page has been professionally reviewed for clarity, balanced medicine information, and alignment with pharmacy practice in Norway.
| Reviewer | Professional credentials |
|---|---|
| Ingrid Solberg | Master of Pharmacy (Cand.pharm.), HPR no. 7852146 |
| Professional reference | Norwegian Directorate of Health |
| Review date | 13 March 2025 |
The review covers Campral (acamprosate), including its role in alcohol-dependence treatment, appropriate use alongside psychosocial support, safety considerations, adverse effects, and the importance of following an individual treatment plan.
Medical disclaimer: This material is provided for informational purposes only and does not replace consultation with a doctor. Seek personalised advice from a doctor or pharmacist before starting, changing, or stopping treatment.
Pharmacy Location and Opening Hours
For Campral, visit our pharmacy at Stenersgata 1, 0050 Oslo, Oslo, Norway.
| Days | Opening hours |
|---|---|
| Monday–Friday | 10:00–21:00 |
| Saturday | 10:00–19:00 |